Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|---|
Filter | GPL24247 | Kevin R King | Oct 03, 2022 | ||||||
GSM6613059 |
Single nuclei, Day0 MI, biol rep 1
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613060 |
Single nuclei, Day0 MI, biol rep 2
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613061 |
Single nuclei, Day0 MI, biol rep 3
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613062 |
Single nuclei, 1HR MI, biol rep 1
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613063 |
Single nuclei, 1HR MI, biol rep 2
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613064 |
Single nuclei, 4HR MI
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613065 |
Single nuclei, Day1 MI, biol rep 1
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613066 |
Single nuclei, Day1 MI, biol rep 2
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613067 |
Single nuclei, Day1 MI, biol rep 3
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613068 |
Single nuclei, Day1 MI, biol rep 4
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613069 |
Single nuclei, Day1 MI, biol rep 5
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613070 |
Single nuclei, Day1 MI, biol rep 6
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613071 |
Single nuclei, Day3 MI, biol rep 1
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613072 |
Single nuclei, Day3 MI, biol rep 2
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613073 |
Single nuclei, Day3 MI, biol rep 3
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613074 |
Single nuclei, Day7 MI, biol rep 1
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613075 |
Single nuclei, Day7 MI, biol rep 2
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613076 |
Single nuclei, Day7 MI, biol rep 3
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613077 |
Visium, Day3 Isoproterenol
|
SRA | 1 | Kevin R King | Oct 03, 2022 | ||||
GSM6613078 |
Visium, 1HR 4HR Day3 Needle Pass, biol rep 1
|
SRA | 1 | Kevin R King | Oct 03, 2022 |